[A pulmonary cellular immunity study in HIV patients] NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[A pulmonary cellular immunity study in HIV patients]

An Med Interna. 1999 Jan;16(1):21-4. Unique Identifier : AIDSLINE MED/99189516
Fernandez Fabrellas E; Gonzalez Constan E; Marin Gonzalez M; Leon P; Blanquer Olivas R; Servicio de Neumologia, Hospital Dr. Peset Aleixandre, Valencia.

Abstract: BACKGROUND: Cellular immunity disorder, showed by a decreased blood level of lymphocytes T CD4, is the main indicator of progression in HIV infection. The diminished level of these lymphocytes and CD4/CD8 ratio in pulmonary samples obtained by bronchoalveolar lavage (BAL) is known, so as the enhanced level of lymphocytes T CD8, while the pulmonary diseases high incidence in these patients could be due to a local immunity disorder or systemic one remains unknown. The aim of this study is to compare systemic immunity disorders, studied in blood samples, with local immunity replay, showed by BAL samples, in patients with HIV infection. METHODS: 74 HIV patients were studied, all of them hospitalized due to acute respiratory disease, and undergone to fiberoptic bronchoscopy for diagnosing. Cellular and lymphocytic populations are compared and measured by flow cytometry in blood and BAL samples. RESULTS: Percentage of total lymphocytes and CD4+ population were decreased in BAL samples, above all in patients with CD4 level minor than 25%. CONCLUSIONS: Cellular immunity disorder of patients with HIV infection is bigger in lung than in blood. It's possible to foresee the lymphocytes T CD4+ pulmonary depletion from their blood levels.
Keywords: JOURNAL ARTICLE Adolescence Adult Bronchoalveolar Lavage Fluid/IMMUNOLOGY Comparative Study English Abstract Female Human HIV Infections/*IMMUNOLOGY *HIV-1 Immunity, Cellular Lung/*IMMUNOLOGY Lymphocyte Count Male Middle Age Prospective Studies Risk FactorsKWDjournalarticleadolescenceadultbronchoalveolarlavagefluid/immunologycomparativestudyenglishabstractfemalehumanhivinfections/KWDimmunologyKWDhiv-1immunity,cellularlung/KWDimmunologylymphocytecountmalemiddleageprospectivestudiesriskfactors
990730
A9971218

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .